Your browser doesn't support javascript.
loading
Serial Bronchoalveolar Lavage Fluid Aspergillus Galactomannan and Treatment Response in Invasive Pulmonary Aspergillosis.
Friedman, Daniel Z P; Theel, Elitza S; Walker, Randall C; Vikram, Holenarasipur R; Razonable, Raymund R; Vergidis, Paschalis.
Afiliación
  • Friedman DZP; Section of Infectious Disease, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Theel ES; Section of Infectious Diseases and Public Health, University of Chicago, Chicago, Illinois, USA.
  • Walker RC; Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Vikram HR; Section of Infectious Disease, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Razonable RR; Division of Infectious Diseases, Mayo Clinic, Phoenix, Arizona, USA.
  • Vergidis P; Section of Infectious Disease, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Open Forum Infect Dis ; 11(4): ofae114, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38560609
ABSTRACT
We studied patients diagnosed with aspergillosis based on positive bronchoalveolar lavage (BAL) Aspergillus galactomannan (GM) who had follow-up BAL sampling within 180 days. GM trend and clinical outcome were concordant in only 60% (30/50). While useful for the initial diagnosis, BAL GM trending does not always correlate with treatment response.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos